© 2001 American Heart Association, Inc.
Molecular Medicine |
Phenotypic Alteration of Vascular Smooth Muscle Cells Precedes Elastolysis in a Mouse Model of Marfan Syndrome
From the Departments of Comparative Medicine and Pathology (T.E.B.), Institute for Genetic Medicine (N.J.B., L.M., H.C.D.), and Howard Hughes Medical Institute (H.C.D.), Johns Hopkins University School of Medicine, Baltimore, Md; and Brookdale Center for Developmental and Molecular Biology (B.G., F.R.), Mount Sinai School of Medicine, New York, NY. Dr Bunton’s present affiliation is Department of Safety Assessment, DuPont Pharmaceuticals Co, Newark, Del.
Correspondence to Harry C. Dietz, Institute for Genetic Medicine, Johns Hopkins Hospital, Ross 858, 720 Rutland Ave, Baltimore, MD 21205. E-mail hdietz{at}jhmi.edu
Abstract—Marfan syndrome is associated with early death due to aortic aneurysm. The condition is caused by mutations in the gene (FBN1) encoding fibrillin-1, a major constituent of extracellular microfibrils. Prior observations suggested that a deficiency of microfibrils causes failure of elastic fiber assembly during late fetal development. Mice homozygous for a targeted hypomorphic allele (mgR) of Fbn1 revealed a predictable sequence of abnormalities in the vessel wall including elastic fiber calcification, excessive deposition of matrix elements, elastolysis, and intimal hyperplasia. Here we describe previously unrecognized concordant findings in elastic vessels from patients with Marfan syndrome. Furthermore, ultrastructural analysis of mgR mice revealed cellular events that initiate destructive changes. The first detectable abnormality was an unusually smooth surface of elastic laminae, manifesting the loss of cell attachments that are normally mediated by fibrillin-1. Adjacent cells adopted alteration in their expression profile accompanied by morphological changes but retained expression of vascular smooth muscle cell markers. The abnormal synthetic repertoire of these morphologically abnormal smooth muscle cells in early vascular lesions included elastin, among other matrix elements, and matrix metalloproteinase 9, a known mediator of elastolysis. Ultimately, cell processes associated with zones of elastic fiber thinning and fragmentation. These data suggest that the loss of cell attachments signals a nonproductive program to synthesize and remodel an elastic matrix. This refined understanding of the pathogenesis of vascular disease in Marfan syndrome will facilitate the development of therapeutic strategies.
Key Words: Marfan syndrome • fibrillin • microfibril • elastin • aneurysm
This article has been cited by other articles:
 |
|
 |
|
  M. Silberbach Bicuspid aortic valve and thoracic aortic aneurysm: toward a unified theory. J. Am. Coll. Cardiol., June 16, 2009; 53(24): 2296 - 2297. [Full Text] [PDF]
|
|
|
|
 |
|
 J. De Backer The expanding cardiovascular phenotype of Marfan syndrome Eur J Echocardiogr, March 1, 2009; 10(2): 213 - 215. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Carta, S. Smaldone, L. Zilberberg, D. Loch, H. C. Dietz, D. B. Rifkin, and F. Ramirez p38 MAPK Is an Early Determinant of Promiscuous Smad2/3 Signaling in the Aortas of Fibrillin-1 (Fbn1)-null Mice J. Biol. Chem., February 27, 2009; 284(9): 5630 - 5636. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Kinsey, M. R. Williamson, S. Chaudhry, K. T. Mellody, A. McGovern, S. Takahashi, C. A. Shuttleworth, and C. M. Kielty Fibrillin-1 microfibril deposition is dependent on fibronectin assembly J. Cell Sci., August 15, 2008; 121(16): 2696 - 2704. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Pearson, R. Devereux, B. Loeys, C. Maslen, D. Milewicz, R. Pyeritz, F. Ramirez, D. Rifkin, L. Sakai, L. Svensson, et al. Report of the National Heart, Lung, and Blood Institute and National Marfan Foundation Working Group on Research in Marfan Syndrome and Related Disorders Circulation, August 12, 2008; 118(7): 785 - 791. [Full Text] [PDF]
|
|
|
|
|
|
M. G. Keane and R. E. Pyeritz Medical Management of Marfan Syndrome Circulation, May 27, 2008; 117(21): 2802 - 2813. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Matt, J. Habashi, T. Carrel, D. E. Cameron, J. E. Van Eyk, and H. C. Dietz Recent advances in understanding Marfan syndrome: should we now treat surgical patients with losartan? J. Thorac. Cardiovasc. Surg., February 1, 2008; 135(2): 389 - 394. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Hassane, N. Claij, I. S. Lantinga-van Leeuwen, J. C. Van Munsteren, N. Van Lent, R. Hanemaaijer, M. H. Breuning, D. J.M. Peters, and M. C. DeRuiter Pathogenic Sequence for Dissecting Aneurysm Formation in a Hypomorphic Polycystic Kidney Disease 1 Mouse Model Arterioscler. Thromb. Vasc. Biol., October 1, 2007; 27(10): 2177 - 2183. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. W.Y. Chung, K. Au Yeung, G. G.S. Sandor, D. P. Judge, H. C. Dietz, and C. van Breemen Loss of Elastic Fiber Integrity and Reduction of Vascular Smooth Muscle Contraction Resulting From the Upregulated Activities of Matrix Metalloproteinase-2 and -9 in the Thoracic Aortic Aneurysm in Marfan Syndrome Circ. Res., August 31, 2007; 101(5): 512 - 522. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. H. Hill, C. M. Ashwell, S. J. Nolin, F. Keeley, C. Billingham, A. Hinek, and B. Starcher Dietary Iron Deficiency Compromises Normal Development of Elastic Fibers in the Aorta and Lungs of Chicks J. Nutr., August 1, 2007; 137(8): 1895 - 1900. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. von Kodolitsch and P. N Robinson Marfan syndrome: an update of genetics, medical and surgical management Heart, June 1, 2007; 93(6): 755 - 760. [Full Text] [PDF]
|
|
|
|
|
|
J. T. Powell and T. Lanne Through Thick and Thin Collagen Fibrils, Stress, and Aortic Rupture: Another Piece in the Jigsaw Circulation, May 29, 2007; 115(21): 2687 - 2688. [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhao, Y. Wen, M. L. Polan, J. Qiao, and B. H. Chen Increased expression of latent TGF-{beta} binding protein-1 and fibrillin-1 in human uterine leiomyomata Mol. Hum. Reprod., May 1, 2007; 13(5): 343 - 349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Hanada, M. Vermeij, G. A. Garinis, M. C. de Waard, M. G.S. Kunen, L. Myers, A. Maas, D. J. Duncker, C. Meijers, H. C. Dietz, et al. Perturbations of Vascular Homeostasis and Aortic Valve Abnormalities in Fibulin-4 Deficient Mice Circ. Res., March 16, 2007; 100(5): 738 - 746. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Schmoker, K. J. McPartland, E. K. Fellinger, J. Boyum, L. Trombley, F. P. Ittleman, C. Terrien III, A. Stanley, and A. Howard Matrix metalloproteinase and tissue inhibitor expression in atherosclerotic and nonatherosclerotic thoracic aortic aneurysms J. Thorac. Cardiovasc. Surg., January 1, 2007; 133(1): 155 - 161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Guo, P. Booms, M. Halushka, H. C. Dietz, A. Ney, S. Stricker, J. Hecht, S. Mundlos, and P. N. Robinson Induction of Macrophage Chemotaxis by Aortic Extracts of the mgR Marfan Mouse Model and a GxxPG-Containing Fibrillin-1 Fragment Circulation, October 24, 2006; 114(17): 1855 - 1862. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P N Robinson, E Arteaga-Solis, C Baldock, G Collod-Beroud, P Booms, A De Paepe, H C Dietz, G Guo, P A Handford, D P Judge, et al. The molecular genetics of Marfan syndrome and related disorders J. Med. Genet., October 1, 2006; 43(10): 769 - 787. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Ikonomidis, J. A. Jones, J. R. Barbour, R. E. Stroud, L. L. Clark, B. S. Kaplan, A. Zeeshan, J. E. Bavaria, J. H. Gorman III, F. G. Spinale, et al. Expression of Matrix Metalloproteinases and Endogenous Inhibitors Within Ascending Aortic Aneurysms of Patients With Marfan Syndrome Circulation, July 4, 2006; 114(1_suppl): I-365 - I-370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-S. Shao, J. Cai, and D. A. Towler Molecular Mechanisms of Vascular Calcification: Lessons Learned From The Aorta Arterioscler. Thromb. Vasc. Biol., July 1, 2006; 26(7): 1423 - 1430. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Carta, L. Pereira, E. Arteaga-Solis, S. Y. Lee-Arteaga, B. Lenart, B. Starcher, C. A. Merkel, M. Sukoyan, A. Kerkis, N. Hazeki, et al. Fibrillins 1 and 2 Perform Partially Overlapping Functions during Aortic Development J. Biol. Chem., March 24, 2006; 281(12): 8016 - 8023. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Characterization of the inflammatory and apoptotic cells in the aortas of patients with ascending thoracic aortic aneurysms and dissections. J. Thorac. Cardiovasc. Surg., March 1, 2006; 131(3): 671 - 678.
|
|
|
|
|
|
Z Szabo, M W Crepeau, A L Mitchell, M J Stephan, R A Puntel, K Yin Loke, R C Kirk, and Z Urban Aortic aneurysmal disease and cutis laxa caused by defects in the elastin gene J. Med. Genet., March 1, 2006; 43(3): 255 - 258. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Laurent, P. Boutouyrie, and P. Lacolley Structural and Genetic Bases of Arterial Stiffness Hypertension, June 1, 2005; 45(6): 1050 - 1055. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Milewicz, H. C. Dietz, and D. C. Miller Treatment of Aortic Disease in Patients With Marfan Syndrome Circulation, March 22, 2005; 111(11): e150 - e157. [Full Text] [PDF]
|
|
|
|
|
|
D. M. Basalyga, D. T. Simionescu, W. Xiong, B. T. Baxter, B. C. Starcher, and N. R. Vyavahare Elastin Degradation and Calcification in an Abdominal Aorta Injury Model: Role of Matrix Metalloproteinases Circulation, November 30, 2004; 110(22): 3480 - 3487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Ramirez, L. Y. Sakai, H. C. Dietz, and D. B. Rifkin Fibrillin microfibrils: multipurpose extracellular networks in organismal physiology Physiol Genomics, October 4, 2004; 19(2): 151 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Boyum, E. K. Fellinger, J. D. Schmoker, L. Trombley, K. McPartland, F. P. Ittleman, and A. B. Howard Matrix metalloproteinase activity in thoracic aortic aneurysms associated with bicuspid and tricuspid aortic valves J. Thorac. Cardiovasc. Surg., March 1, 2004; 127(3): 686 - 691. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Yamazaki Systemic lupus erythematosus with hepatic aneurysm, Valsalva sinus aneurysm and associated polyangiitis: aneurysmal wall remodeling with dense fibrosis and calcification mediated by residual smooth muscle cells Lupus, January 1, 2004; 13(1): 54 - 59. [Abstract] [PDF]
|
|
|
|
|
|
H. Yasuda, S. Nakatani, M. Stugaard, Y. Tsujita-Kuroda, K. Bando, J. Kobayashi, M. Yamagishi, M. Kitakaze, S. Kitamura, and K. Miyatake Failure to Prevent Progressive Dilation of Ascending Aorta by Aortic Valve Replacement in Patients With Bicuspid Aortic Valve: Comparison With Tricuspid Aortic Valve Circulation, September 9, 2003; 108(90101): II-291 - 294. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nataatmadja, M. West, J. West, K. Summers, P. Walker, M. Nagata, and T. Watanabe Abnormal Extracellular Matrix Protein Transport Associated With Increased Apoptosis of Vascular Smooth Muscle Cells in Marfan Syndrome and Bicuspid Aortic Valve Thoracic Aortic Aneurysm Circulation, September 9, 2003; 108(90101): II-329 - 334. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Daniel. V. Bax, S. E. Bernard, A. Lomas, A. Morgan, J. Humphries, C. A. Shuttleworth, M. J. Humphries, and C. M. Kielty Cell Adhesion to Fibrillin-1 Molecules and Microfibrils Is Mediated by {alpha}5{beta}1 and {alpha}v{beta}3 Integrins J. Biol. Chem., September 5, 2003; 278(36): 34605 - 34616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. W.M. Fedak, M. P.L. de Sa, S. Verma, N. Nili, P. Kazemian, J. Butany, B. H. Strauss, R. D. Weisel, and T. E. David Vascular matrix remodeling in patients with bicuspid aortic valve malformations: implications for aortic dilatation J. Thorac. Cardiovasc. Surg., September 1, 2003; 126(3): 797 - 805. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Nienaber and K. A. Eagle Aortic Dissection: New Frontiers in Diagnosis and Management: Part I: From Etiology to Diagnostic Strategies Circulation, August 5, 2003; 108(5): 628 - 635. [Full Text] [PDF]
|
|
|
|
|
|
T. S. Absi, T. M. Sundt III, W. S. Tung, M. Moon, J. K. Lee, R. R. Damiano Jr, and R. W. Thompson Altered patterns of gene expression distinguishing ascending aortic aneurysms from abdominal aortic aneurysms: complementary DNA expression profiling in the molecular characterization of aortic disease J. Thorac. Cardiovasc. Surg., August 1, 2003; 126(2): 344 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Sakomura, H. Nagashima, Y. Aoka, K. Uto, A. Sakuta, S. Aomi, H. Kurosawa, T. Nishikawa, and H. Kasanuki Expression of Peroxisome Proliferator-Activated Receptor-{gamma} in Vascular Smooth Muscle Cells Is Upregulated in Cystic Medial Degeneration of Annuloaortic Ectasia in Marfan Syndrome Circulation, September 24, 2002; 106(12_suppl_1): I-259 - I-263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. W.M. Fedak, S. Verma, T. E. David, R. L. Leask, R. D. Weisel, and J. Butany Clinical and Pathophysiological Implications of a Bicuspid Aortic Valve Circulation, August 20, 2002; 106(8): 900 - 904. [Full Text] [PDF]
|
|
|
|
|
|
C. H. Hill, R. Mecham, and B. Starcher Fibrillin-2 Defects Impair Elastic Fiber Assembly in a Homocysteinemic Chick Model J. Nutr., August 1, 2002; 132(8): 2143 - 2150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Norman, I. Moss, M. Sian, M. Gosling, and J. Powell Maternal and postnatal vitamin D ingestion influences rat aortic structure, function and elastin content Cardiovasc Res, August 1, 2002; 55(2): 369 - 374. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sinha, A. M. Heagerty, C.A. Shuttleworth, and C. M. Kielty Expression of latent TGF-beta binding proteins and association with TGF-beta1 and fibrillin-1 following arterial injury Cardiovasc Res, March 1, 2002; 53(4): 971 - 983. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bailey, H. Xiao, M. Ogle, and N. Vyavahare Aluminum Chloride Pretreatment of Elastin Inhibits Elastolysis by Matrix Metalloproteinases and Leads to Inhibition of Elastin-Oriented Calcification Am. J. Pathol., December 1, 2001; 159(6): 1981 - 1986. [Abstract] [Full Text] [PDF]
|
|